What is Hawthorne Effect?
Hawthorne Effect operates as a specialized provider of decentralized clinical trial solutions, effectively digitizing and streamlining the research lifecycle. Through its proprietary Hawthorne CloudSM platform, the company facilitates comprehensive patient assessments that are no longer tethered to centralized physical sites. This digital infrastructure is complemented by a network of highly trained medical professionals, known as Hawthorne HeroesSM, who execute trial protocols in diverse environments. By prioritizing accessibility and data integrity, the company addresses the persistent challenges of patient recruitment and retention, positioning itself as an essential partner for pharmaceutical and biotech organizations seeking to accelerate their development pipelines.
How much funding has Hawthorne Effect raised?
Hawthorne Effect has raised a total of $20.1M across 2 funding rounds:
Debt
$150K
Series A
$20M
Debt (2020): $150K with participation from PPP
Series A (2021): $20M led by P5 Health Ventures, Northpond Ventures, and SignalFire
Key Investors in Hawthorne Effect
P5 Health Ventures
P5 Health Ventures focuses on investing in companies that enhance healthcare and promote healthier living, with a portfolio spanning diagnostics, artificial intelligence, and wellness solutions.
SignalFire
SignalFire is a venture capital firm that utilizes a proprietary AI platform, Beacon AI, to provide data-driven support and market intelligence to early-stage teams in sectors like healthtech.
Northpond Ventures
Northpond Ventures is a prominent investment firm specializing in science and technology, with a strong focus on life sciences and health-related innovations.
What's next for Hawthorne Effect?
With the recent capital injection, Hawthorne Effect is well-positioned to accelerate its product roadmap and deepen its market penetration. The strategic focus will likely center on enhancing the capabilities of the Hawthorne CloudSM to support increasingly complex trial protocols while scaling the Hawthorne HeroesSM network to meet global demand. As the company matures, it is expected to leverage its data-driven insights to further optimize trial efficiency, potentially setting new industry standards for decentralized research. The ongoing support from high-profile venture partners suggests a strong confidence in the company's ability to disrupt the traditional clinical trial model and capture significant market share in the evolving healthtech ecosystem.
See full Hawthorne Effect company page
